Adam M. Sonabend

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

Junfei Zhao, Andrew Chen, Robyn D. Gartrell et al. · Nature Medicine · 2019 · 956 citations

Medicine, Immunology, Oncology +14

A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma

Priya Kumthekar, Caroline H. Ko, Tatjana Paunesku et al. · Science Translational Medicine · 2021 · 318 citations · Full text

Medicine, Molecular Biology, Oncology +17

MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma

Brian Gill, David J. Pisapia, Hani Malone et al. · Proceedings of the National Academy of Sciences · 2014 · 305 citations · Full text

Medicine, Molecular Biology, Oncology +17

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

Farshad Nassiri, Vikas Patil, Leeor Yefet et al. · Nature Medicine · 2023 · 270 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Peng Zhang, Aida Rashidi, Junfei Zhao et al. · Nature Communications · 2023 · 230 citations · Full text

Medicine, Immunology, Oncology +17